Adenosine: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Adenosine}} | |||
{{CMG}}; {{AE}} {{AZ}} | |||
'''''For patient information, click <u>[[Adenosine (patient information)|here]]'''''</u>. | |||
{{SB}} ADENOCARD®, ADENOSCAN® | |||
==Overview== | |||
==Category== | |||
==FDA Package Insert== | |||
'''| [[Adenosine indications and usage|Indications and Usage]]''' | |||
'''| [[Adenosine dosage and administration|Dosage and Administration]]''' | |||
'''| [[Adenosine dosage forms and strengths|Dosage Forms and Strengths]]''' | |||
'''| [[Adenosine contraindications|Contraindications]]''' | |||
'''| [[Adenosine warnings|Warnings and Precautions]]''' | |||
'''| [[Adenosine adverse reactions|Adverse Reactions]]''' | |||
'''| [[Adenosine drug interactions|Drug Interactions]]''' | |||
'''| [[Adenosine use in specific populations|Use in Specific Populations]]''' | |||
'''| [[Adenosine overdosage|Overdosage]]''' | |||
'''| [[Adenosine description|Description]]''' | |||
'''| [[Adenosine clinical pharmacology|Clinical Pharmacology]]''' | |||
'''| [[Adenosine nonclinical toxicology|Nonclinical Toxicology]]''' | |||
'''| [[Adenosine clinical studies|Clinical Studies]]''' | |||
'''| [[Adenosine how supplied storage and handling|How Supplied/Storage and Handling]]''' | |||
'''| [[Adenosine patient counseling information|Patient Counseling Information]]''' | |||
'''| [[Adenosine labels and packages|Labels and Packages]]''' | |||
==Mechanism of Action== | |||
==References== | |||
{{Reflist|2}} | |||
[[Category:Drugs]] | |||
[[Category:Antiarrhythmic agents]] | |||
Revision as of 16:39, 11 March 2014
| Adenosine |
|---|
| ADENOCARD®, ADENOSCAN® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| Clinical Studies |
| How Supplied/Storage and Handling |
| Labels and Packages |
| Clinical Trials on Adenosine |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
For patient information, click here. Synonyms / Brand Names: ADENOCARD®, ADENOSCAN®
Overview
Category
FDA Package Insert
| Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages